Arbor Capital Management (Minnesota)’s Ligand Pharmaceuticals LGND Stock Holding History

Arbor Capital Management (Minnesota)’s Portfolio LGND Stock Details LGND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-106,527	Closed	-$3.12M	–	175
2014 Q3	$3.12M	Sell	106,527 -232,772	-69%	-$7.73M	0.39%	102
2014 Q2	$13.2M	Sell	339,299 -135,341	-29%	-$5.49M	1.48%	12
2014 Q1	$19.9M	Sell	474,640 -190,425	-29%	-$7.94M	2.1%	3
2013 Q4	$21.8M	Sell	665,065 -46,988	-7%	-$1.53M	1.81%	10
2013 Q3	$20.3M	Sell	712,053 -634,741	-47%	-$17.9M	1.73%	11
2013 Q2	$31.4M	Buy	+1,346,794	New	+$24.2M	2.54%	2

Other funds holding LGND

RIM

RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

DMK

David M. Knott $275M AUM 59.23% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCMLC

Cardinal Capital Management LLC (Connecticut) Greenwich, Connecticut $365M AUM 18.32% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Arbor Capital Management (Minnesota)'s LGND Position: Q4 2014 in Review

Arbor Capital Management (Minnesota) sold out of Ligand Pharmaceuticals (LGND) in Q4 2014, closing a stake of 106,527 shares — an estimated $3.12M sold.

Arbor Capital Management (Minnesota) first reported a position in LGND in Q2 2013 and held it in 6 quarters. The position peaked at $31.4M in Q2 2013. 180 funds tracked by Wall St. Rank hold LGND as of Q4 2014.

Arbor Capital Management (Minnesota) reported no remaining Ligand Pharmaceuticals position as of Q4 2014 after selling out during the quarter.
Arbor Capital Management (Minnesota) sold 106,527 Ligand Pharmaceuticals shares in Q4 2014, an estimated $3.12M.
Arbor Capital Management (Minnesota) first reported a position in Ligand Pharmaceuticals in Q2 2013 and held it in 6 quarters.
Arbor Capital Management (Minnesota)'s Ligand Pharmaceuticals position peaked at $31.4M in Q2 2013.
180 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q4 2014.

Based on Arbor Capital Management (Minnesota)'s 13F filing for Q4 2014, filed 17 Feb 2015.